Skip to main content

Table 3 Correlation of the patients’ resistance profile with the co-expression of the three polymorphisms

From: A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients

Verify-now test

Cases groups

P value (< 0.05)

A group (%)

B group (%)

C group (%)

Non-resistant

23.6

45.8

30.6

0.003**

Resistant

0

40

60

  1. * Statistically significant (Chi square test)